ESC Premium Access

Atrial fibrillation as a factor associated with a finding of non-significant coronary disease on coronary angiography - difficulties in qualifying for coronary angiography - 15 853 patients study

Congress Presentation

About the speaker

Professor Anna Tomaszuk-Kazberuk

Medical University of Bialystok, Bialystok (Poland)
2 presentations
0 follower

11 more presentations in this session

Screening for atrial fibrillation in the primary health care setting

Speaker: Doctor F. Ghazal (Stockholm, SE)


How patient advocacy in partnership with community pharmacy can identify people at risk of AF in community pharmacy setting

Speaker: Mrs T. Lobban (Oxford, GB)


Benefits of active involvement of community pharmacists in know your pulse awareness campaign

Speaker: Mr S. Antoniou (London, GB)


lipid profile and incidence of atrial fibrillation: results from the Kailuan Study

Speaker: Doctor Y. Xia (Dalian, CN)


Prevalence rates of atrial fibrillation tentatively increased during and after the Great East Japan earthquake.

Speaker: Doctor K. Tamaki (Morioka, JP)


Access the full session

Poster session 5 - Demographics and screening

Speakers: Professor A. Tomaszuk-Kazberuk, Doctor F. Ghazal, Mrs T. Lobban, Mr S. Antoniou, Doctor Y. Xia...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb